港股开盘 | 恒指低开0.07% 科网股活跃

Group 1 - The Hang Seng Index opened down 0.07%, while the Hang Seng Tech Index rose by 0.08%. Notably, tech stocks were active, with Baidu increasing by 3.29% as the company evaluates the potential spin-off and listing of Kunlun Chip, although it does not guarantee that the spin-off and listing will occur [1] - Guoyuan International suggests that the direction of the Federal Reserve's decision in December remains uncertain ahead of the release of some recent economic data. The hawkish tone from the Bank of Japan may lead to short-term external disturbances for the Hong Kong stock market. However, the overall valuation level of the Hong Kong market is supported by the Fed's dovish shift and the restoration of dollar liquidity following the reopening of the U.S. government [1] - According to CMB International, the pharmaceutical industry is expected to undergo a critical turning point in 2025. The firm anticipates a stable and positive trend for the sector in 2026, although core factors affecting market performance may show divergence. Short-term focus should be on overseas transactions and performance in innovative drugs, while the CXO sector should be monitored for industry consolidation trends after a bottom reversal [1] Group 2 - Guotai Junan Securities believes that the recent adjustment in the Hong Kong stock market opens up space for an upward trend in 2026. In November, net inflows from southbound funds into the Hong Kong market exceeded 110 billion RMB, indicating strong liquidity and a willingness to accumulate stocks at lower levels [2] - The firm predicts that the Hong Kong stock market could operate between 30,000 and 32,000 points in 2026, reflecting a positive outlook for the market [2]